Making its debut on 01/31/2006, smart beta exchange traded fund SPDR S&P Biotech ETF (XBI) provides investors broad exposure to the Health Care ETFs category of the market. Products that are based ...

Making its debut on 01/31/2006, smart beta exchange traded fund SPDR S&P Biotech ETF (XBI) provides investors broad exposure to the Health Care ETFs category of the market. What Are Smart Beta ETFs?

Day One Biopharmaceuticals focuses on pediatric cancer treatments. Read more about the biotech's therapies and its prospects ...

The healthcare sector is poised for strong growth, driven by aging populations, technological advancements, and increased ...

You should consider the VanEck Biotech ETF (BBH), a passively managed exchange traded fund launched on 12/20/2011. Passively managed ETFs are becoming increasingly popular with institutional as ...

Comparatively, 32.0% of VanEck Biotech ETF shares are held by institutional investors. 1.0% of BlackRock MuniYield New York Quality Fund shares are held by insiders. Strong institutional ownership ...

Jane Street Group LLC lifted its stake in shares of VanEck Biotech ETF (NASDAQ:BBH – Free Report) by 401.7% in the third quarter, according to the company in its most recent disclosure with the SEC.

Health care stocks trended downward for most of 2024, significantly underperforming broader stock indexes. Over the past year, the S&P 500 Health Care index rose by only 0.